No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
KMX CarMax
- 67.880
- -0.460-0.67%
Close Apr 22 16:00 ET
10.68BMarket Cap22.48P/E (TTM)
68.690High67.310Low1.88MVolume68.400Open68.340Pre Close127.91MTurnover1.20%Turnover Ratio22.48P/E (Static)157.39MShares88.22052wk High1.76P/B10.63BFloat Cap59.66052wk Low--Dividend TTM156.60MShs Float155.980Historical High--Div YieldTTM2.02%Amplitude0.656Historical Low67.882Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CarMax Unveils Latest Trends in Used EV Shopping
Richmond, VA, April 22, 2024 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE:KMX), the nation's largest retailer of used cars, has released its latest findings on consumer trends in used electric vehicle (EV) shopping. The
Analysts Offer Insights on Consumer Cyclical Companies: Bosideng International Holdings (OtherBSDGF), CarMax (KMX) and Genting Singapore (OtherGIGNF)
J.P. Morgan's Analyst Focus List - 5 Adds and 1 Removal
Express News | NYSE Order Imbalance 140485.0 Shares on Buy Side 140485.0 Shares on Buy Side
Express News | NYSE Order Imbalance 170388.0 Shares on Buy Side
Express News | Wedbush Reiterates Outperform on CarMax, Maintains $90 Price Target
Comments
ColumnsToday's Morning Movers and Top Ratings: NKE, AMZN, KMX, V and More
Morning Movers
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
28
Analysts predict CarMax's earnings report could boost stock gains, turning a modest sales rise into a larger earnings increase through cost control. They also foresee potential for mid-single-digit annual revenue growth over the next three years if online sales persist. Needham analyst Chris Pierce upgraded the stock to Buy from Hold on March 20, with a price target of $99.
1
Despite some analysts' optimism, Wall Street remains skeptical about CarMax, with less than half recommending a Buy. Carvana's average price target suggests a 28% drop. Concerns linger about Amazon's entry into auto sales and the volatile used car market.
2
The declining ROCE and sales for CarMax, along with the increased capital employment, are concerning. Despite the stock's rise in the last five years, the current trends do not inspire confidence in the company's future performance.
Oppenheimer sees Vroom's departure as a chance for CarMax to gain market share and face one less national rival. The firm also highlights potential demand due to aging vehicles in the U.S. and consumers returning to the market as affordability improves.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg